Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)
Fennec Pharmaceuticals posted quarterly Capital Expenditures of $1.7 million for Q1 2024.
Fennec Pharmaceuticals (FENC) has 1 years of Capital Expenditures data on file, last reported at $1.7 million in Q1 2024.
- For the quarter ending Q1 2024, Capital Expenditures changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Jun 2024 stood at $1.7 million (changed N/A YoY), and the FY2022 full-year result was $175000.0, changed N/A from the prior year.
- Capital Expenditures for Q1 2024 stood at $1.7 million.
- Across five years, Capital Expenditures topped out at $1.7 million in Q1 2024 and bottomed at $1.7 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.74 Mn |